CIK 0000873303
- Large accelerated filer
Sarepta Therapeutics, Inc.
Sign in to watch- Ticker
- SRPT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 930797222
- Phone
- +1 617-274-4000
- Business address
- 215 FIRST STREET, SUITE 415, CAMBRIDGE, MA, 02142
- Former names
- Sarepta Therapeutics, Inc., AVI BIOPHARMA INC, ANTIVIRALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-08-14 | Chambers Michael Andrew Director | Purchase | +4,032 | $109.89 | $443K | 246,996 |
| 2023-08-11 | Chambers Michael Andrew Director | Purchase | +23,686 | $108.05 | $2.6M | 237,017 |
| 2023-08-10 | Chambers Michael Andrew Director | Purchase | +2,206 | $104.67 | $231K | 180,670 |
| 2023-08-10 | Chambers Michael Andrew Director | Purchase | +1,091 | $105.90 | $116K | 181,761 |
| 2023-08-10 | Chambers Michael Andrew Director | Purchase | +31,570 | $106.26 | $3.4M | 213,331 |
| 2023-08-04 | Wigzell Hans Lennart Rudolf Director | Exercise or conversion | +15,000 | $29.03 | $435K | 35,994 |
| 2023-08-04 | Wigzell Hans Lennart Rudolf Director | Sale | −15,000 | $106.72 | $1.6M | 20,994 |
| 2023-08-04 | Wigzell Hans Lennart Rudolf Director | Exercise or conversion · Stock Option (right to buy) | −15,000 | 0 | ||
| 2023-06-01 | Brown Ryan Edward EVP, General Counsel | Shares withheld for taxes | −89 | $123.60 | $11K | 28,096 |
| 2023-03-30 | Arif Bilal Chief Tech Ops Officer | Shares withheld for taxes | −307 | $136.66 | $42K | 26,367 |
| 2023-03-08 | Rodino-Klapac Louise Head of R&D, CSO | Shares withheld for taxes | −912 | $153.19 | $140K | 70,170 |
| 2023-03-08 | Estepan Ian Michael Chief Financial Officer | Shares withheld for taxes | −744 | $153.19 | $114K | 34,679 |
| 2023-03-08 | Brown Ryan Edward SVP, General Counsel | Shares withheld for taxes | −635 | $153.19 | $97K | 28,185 |
| 2023-03-08 | Arif Bilal Chief Tech Ops Officer | Shares withheld for taxes | −314 | $153.19 | $48K | 26,674 |
| 2023-03-06 | Estepan Ian Michael Chief Financial Officer | Shares withheld for taxes | −1,370 | $157.21 | $215K | 30,923 |
| 2023-03-06 | Estepan Ian Michael Chief Financial Officer | Grant or award | +4,500 | 35,423 | ||
| 2023-03-06 | Estepan Ian Michael Chief Financial Officer | Grant or award · Stock Option (right to buy) | +27,000 | 27,000 | ||
| 2023-03-06 | Rodino-Klapac Louise Head of R&D, CSO | Shares withheld for taxes | −1,134 | $157.21 | $178K | 66,582 |
| 2023-03-06 | Rodino-Klapac Louise Head of R&D, CSO | Grant or award | +4,500 | 71,082 | ||
| 2023-03-06 | Rodino-Klapac Louise Head of R&D, CSO | Grant or award · Stock Option (right to buy) | +27,000 | 27,000 |
Page 15 of 22 · 424 trades